Now showing items 1-5 of 5
Chronic kidney disease in general populations and primary care: diagnostic and therapeutic considerations.
PURPOSE OF REVIEW: The majority of people with chronic kidney disease (CKD) are managed by primary care physicians and nurses, but much of the initial research on CKD care was based in secondary care. The purpose of this ...
Remote ischaemic conditioning-therapeutic opportunities in renal medicine.
Following ischaemic insult, tissue damage is extended after reperfusion, known as an ischaemia reperfusion injury. Ischaemic conditioning-the application of transient, non-lethal, episodes of ischaemia-reduces the effect ...
Tissue advanced glycation end product deposition after kidney transplantation.
BACKGROUND: Tissue advanced glycation end products (AGEs) accumulate in chronic kidney disease (CKD) and are a measure of cumulative metabolic stress. Measurement of tissue AGEs by skin autofluorescence (SAF) correlates ...
Determinants of arterial stiffness in chronic kidney disease stage 3.
BACKGROUND: Early chronic kidney disease (CKD) is associated with increased cardiovascular (CV) risk but underlying mechanisms remain uncertain. Arterial stiffness (AS) is associated with increased CV risk in advanced CKD, ...
Natural history of skeletal muscle mass changes in chronic kidney disease stage 4 and 5 patients: an observational study.
Cross-sectional studies in dialysis demonstrate muscle wasting associated with loss of function, increased morbidity and mortality. The relative drivers are poorly understood. There is a paucity of data regarding interval ...